2012 Leveling the playing field: Bringing development of biomarkers and molecular diagnostics up to the standards for drug development
Complex Adaptive Systems Initiative
2012 Leveling the playing field: Bringing development of biomarkers and molecular diagnostics up to the standards for drug development
George Poste, David P. Carbone, David R. Parkinson, et al. Clin Cancer Res 2012;18:1515-1523. Published online March 14, 2012. Abstract: Molecular diagnostics are becoming increasingly important in clinical research to
The way we do science: saving America’s knowledge enterprise
Future Tense forum – “How to Save America’s Knowledge Enterprise from Tight Budgets, Primitive Myths & the Shadow of Albert Einstein” – scheduled for 12 to 5:30 p.m., May 21,
Six steps to fix our public health agencies’ testing capabilities in the pandemic
The following piece is adapted from a panel discussion on Day 2 of the 2020 Future Security Forum: Reimagining National Security in the Age of COVID-19, featuring remarks from ASU’s Chief
Inaugural Workshop: National Biomarker Development Alliance (NBDA)
The NBDA inaugural workshop is Workshop I in a series that will, over the next several months, bring together groups of experts from all sectors to specifically identify the level
ASU expertise in analytics helps bring major international conference to Phoenix
“Among featured speakers will be ASU professors George Poste and Edward Prescott. Poste is an ASU Regents’ Professor, chief scientist of the university’s Complex Adaptive Systems Initiative and the Del
Dr. George Poste speaking at the PMWC 2017 Silicon Valley
(co-hosted by Stanford, UCSF, Intermountain Healthcare) on January 23-25, 2017.
Dr. George Poste speaking at the Cambridge Healthtech Institute’s Biomarkers and Immuno-Oncology World Congress, May 2-4, 2017
Dear Colleague. I am giving a talk at Cambridge Healthtech Institute’s Biomarkers and Immuno-Oncology World Congress, May 2-4, 2017 in Philadelphia. The congress features more than 100 speakers in 6
Member, International Ebola Vaccine Team B Report (2015) “Osterholm, M. et al. (2015) The Ebola Vaccine Team B: a model for promoting the rapid development of medical countermeasures for emerging infectious disease threats. Lancet Infect. Dis.
Members listed at the end of the paper. Published Online: 30 October 2015
Geneticist, informatics expert Buetow to lead new research program at ASU
Kenneth H. Buetow, a human geneticist and former director of the Center for Biomedical Informatics and Information Technology at the National Cancer Institute, is joining Arizona State University as director
ASU experts grapple with gene-based medicine questions on PBS
Sooner than we think, we will have access to our own genetic codes. Are we ready to join the DNA generation? Two ASU researchers, Gary Marchant and George Poste, will